Mechanisms associated with post-stroke depression and pharmacologic therapy

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Post-stroke depression (PSD) is a frequent neuropsychiatric complication following stroke, significantly impacting patient recovery and quality of life.
• Its underlying mechanisms are complex, involving neurotransmitter imbalances, neuroinflammation, neuroendocrinology, neurotrophic factors, and lesion site characteristics.

Purpose of the Study:

• To review the current understanding of PSD mechanisms.
• To summarize established and emerging pharmacological treatments for PSD.
• To highlight the need for further research into PSD etiology and treatment.

Main Methods:

• Literature review of studies on PSD mechanisms.
• Analysis of clinical studies on pharmacological interventions for PSD.
• Synthesis of current research findings on PSD treatment efficacy.

Main Results:

• Neurotransmitter systems, particularly serotonin, are implicated in PSD, with selective serotonin-reuptake inhibitors (SSRIs) showing efficacy.
• Other factors like neuroinflammation, neuroendocrinology, neurotrophic factors, and stroke lesion location influence PSD development.
• Pharmacological treatments including SSRIs, NaSSAs, anti-inflammatory drugs, and vitamin D have demonstrated effectiveness in clinical studies.

Conclusions:

• While progress has been made, the precise mechanisms of PSD remain incompletely understood.
• Current treatments offer benefits, but further research is essential for comprehensive prevention and management strategies.
• Continued investigation into PSD mechanisms and therapeutic options is crucial for improving patient outcomes.